ADPKD Guide
Readable, evidence-first ADPKD treatment, symptoms, diet, trials, and research updates for patients, families, and clinicians.
Last sweep: Jun 1, 2026
What’s New Methodology References Support GitHub
Ask ADPKD Patient Guide Treatment Slow Progression Trials Cure
More
What’s New Newly Diagnosed Tolvaptan Lifestyle Diet Symptoms Clinicians Methodology References Support
Newly Diagnosed ADPKD First steps

Start with structure, not panic

Most people with ADPKD live decades with normal kidney function. What you do in the first year — blood pressure, monitoring, understanding your risk — matters more than any supplement or diet trend.

Last reviewed: July 23, 2026

The three things that matter most right now

1. Control blood pressure

Target: < 130/80 mmHg at home

High blood pressure is the earliest and most damaging feature of ADPKD. It starts in up to 70% of patients before eGFR even drops. ACE inhibitors or ARBs are first-line. Low sodium amplifies their effect.

Buy a validated upper-arm cuff and track twice daily. Your readings at home are more useful than occasional clinic readings.

2. Reduce sodium

Target: < 2 g sodium/day

Sodium drives blood pressure in ADPKD through RAAS activation. Cutting sodium is the most diet-related action with guideline backing. This is not a special ADPKD thing — it is standard kidney-protective care.

Read food labels. Processed foods, bread, deli meats, and restaurant meals are the main sources — not your salt shaker.

3. Know your progression risk

Ask about your Mayo Classification

Not everyone with ADPKD progresses at the same speed. The Mayo Classification (1A to 1E) uses kidney volume and age to estimate your likely rate of progression. Class 1C and above is considered rapidly progressing.

Your Mayo Class determines whether tolvaptan makes sense, how often to get imaging, and what your risk of ESRD looks like over time.

Is there a treatment?

Tolvaptan (Jynarque, JINARC, Samsca) is the only FDA/EMA approved drug shown to slow kidney function decline in appropriate adults with rapidly progressing ADPKD. It works by reducing the hormonal signal that drives cyst fluid secretion.

It is not for everyone. It requires a specific risk profile (usually Mayo Class 1C+), regular liver monitoring, and you must tolerate frequent urination and thirst. Some people find the side effects manageable; others do not.

If tolvaptan is not appropriate for you right now, you are not out of options. Blood pressure control and sodium reduction are proven strategies available to everyone, regardless of tolvaptan eligibility.

Full tolvaptan guide Full treatment overview

Promising but not yet proven

  • SGLT2 inhibitors (dapagliflozin, empagliflozin) — encouraging observational and early trial data. Not yet guideline-approved for ADPKD. Trials underway.
  • Ketogenic diet — feasibility shown; no trial has proven it slows progression yet.
  • Gene therapy — one early Phase 2a trial is running. Not available for standard care. Years away at minimum.
What may slow progression Cure research reality

What is NOT proven (despite what you may read)

  • High water intake alone does not slow ADPKD. A 3-year randomised controlled trial (PREVENT-ADPKD, Burgess et al. NEJM 2018) found no benefit. Stay hydrated normally — do not drink 3–4 litres specifically to "suppress vasopressin."
  • No cure exists yet. Anyone claiming a supplement, diet, or therapy cures ADPKD is wrong. Gene therapy is in early trials — not available.
  • Supplements (turmeric, resveratrol, green tea, herbal remedies) have no credible ADPKD trial evidence. Some may interact with medications.
  • One person's story is not evidence. Progression varies enormously between individuals — what worked for someone in a Facebook group may reflect their natural variation, not a treatment effect.

What to track every year

  • Blood pressure — home log, twice daily when first diagnosed or adjusting medications
  • eGFR and creatinine — your kidney function trend over years matters more than any single reading
  • Urine albumin-to-creatinine ratio (ACR) — early marker of kidney filtration pressure
  • Kidney imaging — MRI is most accurate for volume; frequency depends on your risk class
  • Liver cysts — common and usually benign; should be monitored especially in women
  • Blood pressure medication effectiveness — adjustment is normal over time
Symptoms guide Diet guide

Questions to ask your nephrologist — by situation

Print this page or screenshot it before your appointment. You do not need to ask everything at once.

At your first or early appointment
  • QWhat is my eGFR, and what has the trend been over the last 2–3 years?
  • QWhat is my total kidney volume, and when was it last measured?
  • QWhat is my Mayo Classification — am I Class 1A, B, C, D, or E?
  • QAm I a candidate for tolvaptan now, or in the future?
  • QWhat blood pressure target should I aim for at home?
  • QShould I switch to an ACE inhibitor or ARB if I am not on one?
  • QHow often should I have kidney imaging?
About family members and genetics
  • QShould I see a genetic counsellor — especially if I am planning a family?
  • QWhich of my first-degree relatives should get screened?
  • QShould genetic testing be done to identify my specific mutation (PKD1 vs PKD2)?
  • QWhat do I tell my children about ADPKD and screening age?
If you are considering tolvaptan
  • QDo I meet the Mayo Class 1C+ or PROPKD score criteria for tolvaptan?
  • QWhat monitoring will I need — how often are liver tests required?
  • QWhat do I do if I cannot tolerate the frequent urination?
  • QWhat is the cost and does my insurance or public plan cover it?
  • QWhat happens if I need to stop it — does my progression accelerate?
About clinical trials and future options
  • QAre there any clinical trials I might be eligible for?
  • QWhat SGLT2 inhibitor trials are available near me?
  • QIf my eGFR continues to decline, when should we discuss transplant planning?
  • QWhat would disqualify me from kidney transplant if I ever need one?
  • QWho else should be on my care team — dietitian, genetic counsellor, cardiologist?

Find an ADPKD-experienced nephrologist near you

Not all nephrologists specialise in ADPKD or are familiar with tolvaptan candidacy, Mayo Classification, or current trial evidence. If you are not already with a specialist, it is worth seeking one out — especially in the first year after diagnosis.

When searching, use terms like "PKD specialist", "polycystic kidney disease", or "ADPKD clinic" — not just "nephrologist near me."

Search Google for ADPKD specialist

On iPhone: opens Apple Maps. On Android or desktop: opens Google Maps. Both search for kidney specialists in your area.